Focal Nodular Hyperplasia
Focal nodular hyperplasia (FNH) is the second most common benign tumor of the liver and comprises approximately 8% of the primary hepatic tumors. Although benign liver tumors are relatively rare lesions and are usually unrelated to subjective symptoms, they are increasingly being diagnosed as a result of the widespread use of ultrasound, computed tomography, and magnetic resonance in the evaluation of patients with non-specific abdominal symptoms.
The pathogenesis of FNH is not well understood, although it is usually considered to be a nonneoplastic, hyperplastic response to a congenital vascular malformation. The characteristic histological features of FNH include a dense, central stellate scar and septa that radiate from the central scar. The septa divide the tumor into several nodules. The hepatic parenchyma between the septa is composed of hepatocytes, sinusoids, and Kupffer cells. FNH does not have a tumor capsule, although the pseudo capsule surrounding some FNH lesions may be quite prominent. The pseudo capsule of FNH results from compression of the surrounding parenchyma by the FNH, perilesional vessels, and inflammatory reaction. It typically shows high signal intensity on T2-weighted images and enhancement on delayed contrast-enhanced images. Generally, the central scar shows enhancement on delayed contrast-enhanced images. The central scar is not a specific finding of FNH and can be seen in a variety of other focal liver lesions. A central area of scarring can also be seen in fibrolamellar hepatocellular carcinoma and large hemangiomas, and, rarely, in cholangiocarcinoma, some hepatic metastases, and non-fibrolamellar HCCs.
Multiphase MDCT, dynamic contrast-enhanced ultrasound and MRI usually determine that a lesion is a FNH. However, atypical FNH can appear as a large lesion, sometimes in multiple locations. The tumor may show less intense enhancement, unusual appearance or non-enhancement of the central scar, and pseudo capsular enhancement on delayed images. In these cases, it may be difficult to differentiate atypical FNH from lesions such as hepatic adenoma, HCC, fibrolamellar carcinoma and hypervascular hepatic metastases. MRI using liver-specific CM targeted at the Kupffer cells and hepatocytes can demonstrate the hepatocellular origin of the lesion.
Although FNH may grow to more than 10 cm, patients are occasionally symptomatic, and most show a normal liver function test. Malignant transformation of FNH has not been clearly described. Usually treatment of FNH includes conservative clinical follow-up in asymptomatic patients. Surgical resection is indicated for those with significant symptoms or in whom malignancy cannot be excluded by radiological and histological studies.
In this issue of Acta Radiologica, LANGREHR et al. report on the histological findings of HCC in two patients of their whole material of 77 resected FNHs (1) . In these two cases, the FNH lesion grew rapidly. However, rapid growth in a FNH lesion can be observed without malignancy. This report is interesting because the normal procedure for verified FNHs is often conservative. Is this strategy sufficient? As stated by the author, rapid growth of FNH should raise the suspicion of a concomitant malignant disease.
It is speculative whether FNH is oncogenic or whether the growth pattern of FNH is a local reaction to an area of HCC. However, the conclusion of the authors that a tendency to rapid growth and a heterogeneous imaging appearance of a FNH do that, a surgical strategy should be considered.
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